Table: Immuno Biological Lab -2025/26 group results

Immuno-Biological Laboratories

13/05/2026 07:38

May 13 (Reuters)- 
          Immuno Biological Laboratories Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2026    Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           1.00           969 mln         1.09                  
               (+3.7 pct)      (+18.7 pct)    (+8.2 pct)               
  Operating      281 mln         209 mln        322 mln                
               (+34.4 pct)    (+100.7 pct)    (+14.5 pct)              
  Recurring      300 mln         209 mln        322 mln                
               (+43.2 pct)     (+67.3 pct)    (+7.1 pct)               
  Net
  Net            329 mln         249 mln        347 mln                
               (+32.1 pct)     (+33.4 pct)    (+5.5 pct)               
  EPS           35.33 yen       26.74 yen      37.26 yen               
  Ann Div       6.00 yen           NIL         7.50 yen                
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       6.00 yen           NIL         7.50 yen                
  
  NOTE - Immuno Biological Laboratories Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T